摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(1-methylethoxy)-3-phenyl-2-propylamine hydrochloride | 64715-89-5

中文名称
——
中文别名
——
英文名称
1-(1-methylethoxy)-3-phenyl-2-propylamine hydrochloride
英文别名
(S)-(+)-1-methoxy-2-amino-3-methylbutane hydrochloride;(S)-1-methoxy-3-methylbutan-2-amine hydrochloride;(2s)-1-Methoxy-3-methyl-2-butanamine hydrochloride;(2S)-1-methoxy-3-methylbutan-2-amine;hydrochloride
1-(1-methylethoxy)-3-phenyl-2-propylamine hydrochloride化学式
CAS
64715-89-5
化学式
C6H15NO*ClH
mdl
——
分子量
153.652
InChiKey
MELMFNVCMMMNKN-FYZOBXCZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    166.5-168.5 °C(Solv: ethanol (64-17-5); ethyl ether (60-29-7))

计算性质

  • 辛醇/水分配系数(LogP):
    1.04
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    35.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Stereoselective Reactions. 25. Enantioselective Deprotonation of Prochiral 4-Substituted Cyclohexanones by Chiral Chelated Lithium Amides
    作者:Ryuichi Shirai、Daisaku Sato、Kazumasa Aoki、Masahide Tanaka、Hisashi Kawasaki、Kenji Koga
    DOI:10.1016/s0040-4020(97)00288-3
    日期:1997.4
    4-substituted cyclohexanones (4a∼d) by chiral chelated lithium amides (8a≈k) in the presence of excess trimethylsilyl chloride was realized to give the corresponding chiral silyl enol ethers (6a∼d) in up to 89% ee. It is shown that enantioselectivity of the reaction is dependent on the solvent used, but becomes almost independent on the solvent in the presence of HMPA. The sense of asymmetric induction
    在过量的三甲基甲硅烷基氯存在下,通过手性螯合锂酰胺(8a≈k)对前手性4-取代的环己酮(4a〜d)进行对映选择性去质子化反应,得到相应的手性甲硅烷基烯醇醚(6a〜d)的比例高达89% ee。结果表明,反应的对映选择性取决于所用的溶剂,但在HMPA存在下,其对映选择性几乎与溶剂无关。不对称诱导的感觉可以与锂酰胺的手性碳在带有手性碳的酰胺氮上的构型相关。©1997爱思唯尔科学有限公司。
  • 7-SUBSTITUTED 1-ARYL-NAPHTHYRIDINE-3-CARBOXYLIC ACID AMIDES AND USE THEREOF
    申请人:Bayer Aktiengesellschaft
    公开号:US20190263805A1
    公开(公告)日:2019-08-29
    The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
    本申请涉及新颖的7-取代的1-芳基喹啉并吡啶-3-羧酰胺,其制备方法,其单独或组合使用,用于治疗和/或预防疾病,以及用于生产药物以治疗和/或预防疾病,特别是用于治疗和/或预防心血管疾病和/或肾脏疾病。
  • Mild N-deacylation of secondary amides by alkylation with organocerium reagents
    作者:Ai-E Wang、Zong Chang、Yong-Peng Liu、Pei-Qiang Huang
    DOI:10.1016/j.cclet.2015.05.033
    日期:2015.9
    Secondary amides are a class of highly stable compounds serving as versatile starting materials, intermediates and directing groups (amido groups) in organic synthesis. The direct deacylation of secondary amides to release amines is an important transformation in organic synthesis. Here, we report a protocol for the deacylation of secondary amides and isolation of amines. The method is based on the activation
    摘要仲酰胺是一类高度稳定的化合物,可作为有机合成中的通用原料,中间体和指导基团(酰胺基)。仲酰胺的直接脱酰以释放胺是有机合成中的重要转变。在这里,我们报告了仲酰胺脱酰和胺分离的方案。该方法基于用Tf 2 O活化酰胺,然后添加有机铈试剂,然后进行酸性处理。反应在温和的条件下进行,以高收率得到相应的胺,以其盐酸盐的形式分离出来。与CH活化功能化方法相结合,该方法适用于苯胺的功能化以及羧酸衍生物向功能化酮的转化。
  • Novel aspartyldipeptide derivatives and sweetener
    申请人:Ajinomoto Co., Inc.
    公开号:EP0691346A1
    公开(公告)日:1996-01-10
    A low-calory sweetener is provided which is highly stable and safe and has a high sweetness potency. This sweetener comprises novel aspartyldipeptide derivatives of the following general formula (1) and their salts:         L-Asp-X-NH-C*HR₁R₂   (1) wherein R₁ represents an alkyl group having from 1 to 6 carbon atoms, or an alkoxymethyl group having from 2 to 7 carbon atoms; R₂ represents a phenyl group, a benzyl group, a cyclohexyl group, or a cyclohexylmethyl group; the structure having the C* atom is of an (S) form when R₁ is an alkyl group but is of an (R) form when R₁ is an alkoxymethyl group; X represents a residue of a D-α-amino acid or DL-α-amino acid, or a residue of a cyclic or acyclic α,α-dialkylamino acid having from 3 to 6 carbon atoms, when R₁ is an alkyl group, but X represents a residue of a D-α-amino acid or DL-α-amino acid, or a residue of a cyclic or acyclic α,α-dialkylamino acid having from 3 to 6 carbon atoms, when R₁ is an alkoxymethyl group; and the bond between L-Asp and X is an α-bond.
    本发明提供了一种低热量甜味剂,它具有高度稳定性和安全性,并具有较高的甜味效力。这种甜味剂包括以下通式(1)的新型天冬二肽衍生物及其盐类: L-Asp-X-NH-C*HR₁R₂ (1) 其中 R₁ 代表具有 1 至 6 个碳原子的烷基,或具有 2 至 7 个碳原子的烷氧基甲基;R₂ 代表苯基、苄基、环己基或环己基甲基;当 R₁ 为烷基时,具有 C* 原子的结构为 (S) 形式,但当 R₁ 为烷氧基甲基时,具有 C* 原子的结构为 (R) 形式;当 R₁ 是烷基时,X 代表 D-α-氨基酸或 DL-α-氨基酸的残余物,或具有 3 至 6 个碳原子的环状或非环状 α,α-二烷基氨基酸的残余物、但当 R₁ 为烷氧基甲基时,X 代表 D-α-氨基酸或 DL-α-氨基酸的残基,或具有 3 至 6 个碳原子的环状或非环状 α,α-二烷基氨基酸的残基;L-Asp 与 X 之间的键为α键。
  • 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
    申请人:Bayer Aktiengesellschaft
    公开号:US10927109B2
    公开(公告)日:2021-02-23
    The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
    本申请涉及新型 7-取代 1-芳基萘啶-3-羧酰胺、其制备工艺、其单独或组合用于治疗和/或预防疾病的用途,以及其用于生产治疗和/或预防疾病,特别是治疗和/或预防心血管疾病和/或肾脏疾病的药物。
查看更多